These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24129137)

  • 21. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.
    Sieper J; Lenaerts J; Wollenhaupt J; Rudwaleit M; Mazurov VI; Myasoutova L; Park S; Song Y; Yao R; Chitkara D; Vastesaeger N;
    Ann Rheum Dis; 2014 Jan; 73(1):108-13. PubMed ID: 23740231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials.
    Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S19-21. PubMed ID: 24129131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can biologic therapies be withdrawn or tapered in psoriatic arthritis?
    Moverley AR; Coates LC; Helliwell PS
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S51-3. PubMed ID: 24129138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
    Prince DS; McGuigan LE; McGirr EE
    Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications.
    Perrotta FM; De Socio A; Scriffignano S; Lubrano E
    Expert Rev Clin Immunol; 2018 Mar; 14(3):207-213. PubMed ID: 29338498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission in ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-88-92. PubMed ID: 17083769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis.
    Robinson PC; Benham H
    Intern Med J; 2015 Feb; 45(2):127-33. PubMed ID: 25132517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
    Lubrano E; Soriano E; FitzGerald O
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S54-8. PubMed ID: 24129139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous versus intermittent therapy for moderate-to-severe psoriasis.
    Ramirez-Fort MK; Levin AA; Au SC; Gottlieb AB
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S63-70. PubMed ID: 24129141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis.
    de Andrade KR; de Castro GR; Vicente G; da Rosa JS; Nader M; Pereira IA; Fröde TS
    Int Immunopharmacol; 2014 Aug; 21(2):481-6. PubMed ID: 24925756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current therapy with TNFalpha blocking agents for ankylosing spondylitis and undifferentiated spondyloarthritis].
    Brandt J; Sieper J; Braun J
    Z Rheumatol; 2004 Jun; 63(3):203-10. PubMed ID: 15224223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.
    Poddubnyy D; Rudwaleit M
    Expert Opin Biol Ther; 2013 Nov; 13(11):1599-611. PubMed ID: 24074224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.
    Otsuka A; Morita M; Yamada H
    J Orthop Sci; 2015 Nov; 20(6):1070-7. PubMed ID: 26245191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Spondyloarthritis - the novel concept. An introduction to the diagnosis and treatment of axial spondyloarthritis].
    Kiltz U; Baraliakos X; Braun J
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1745-7. PubMed ID: 22933197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tapering and termination of immunosuppressive treatment in spondyloarthritides (including psoriatic arthritis)].
    Scholz G; Möller B
    Z Rheumatol; 2017 Feb; 76(1):21-26. PubMed ID: 27933391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; Van Den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
    Arthritis Care Res (Hoboken); 2016 Feb; 68(2):151-66. PubMed ID: 26401907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.
    Spadaro A; Lubrano E; Marchesoni A; Cauli A; Cantini F; Carotti M; D'Angelo S; Grassi W; Lapadula G; Macchioni P; Mathieu A; Punzi L; Ramonda R; Salaffi F; Salvarani C; Scarpa R; Olivieri I
    Clin Exp Rheumatol; 2014; 32(4):465-70. PubMed ID: 24850468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.